Alcoholism and Its Complications
At the end of this talk learners should be able to apply an understanding of:
- DSM 5 definition of alcohol use disorders
- Epidemiology of alcohol use disorders, genetic and cultural predictors of alcoholism and of treatment response, metabolism and measures of blood alcohol content in men and women.
- Pharmacologic interventions for alcohol use disorders and evidence base. Include something about which patients do well with anti-depressants.
- Mechanisms of alcohol-drug interactions (list common meds that interact)
- Alcohol in the workplace, pertaining to absenteeism, injury at work, effect on healthcare utilization
- Office based screening tools and labs for ETOH screening
- Clinical management of intoxication, withdrawal, detox
- Medical sequelae as well as impact on other chronic medical conditions (ie hep C, diabetes, heart disease) and impact on psychiatric conditions.
Anthony Albanese, MD
Dr. Albanese is Chief of Hepatology at the VA Northern California Healthcare System and Clinical Professor of Medicine and Psychiatry at the UC Davis School of Medicine. He was the 2012 Review Course Chairman and is now on the CSAM Executive Council. He has been practicing Addiction Medicine and Hepatology for the past 21 years in a variety of settings including methadone clinic, private practice, full service treatment facilities, academic centers and impaired professional programs.
Dr. Albanese: AbbVie: Speaker's Bureau; Genentech: Speakers Bureau; Gilead: Speakers Bureau; Merck: Speaker's Bureau
- 1.00 California Board of Behavioral Sciences
- 1.00 NCCPA
- 1.00 AAPA
- 1.00 AMA Category 1
- 1.00 CAADAC